Rafael Fonseca, MD, is the Getz Family Professor of Cancer, Professor of Medicine, Interim Executive Director of the Mayo Clinic Comprehensive Cancer Center, Director for Innovation and Transformational Relationships, and a consultant in the Division of Hematology/Oncology at the Mayo Clinic in Arizona. Dr. Fonseca is a hematologist specializing in the care and research of multiple myeloma and related conditions. He participates and leads clinical trials that have led to the approval of various drugs for the treatment of myeloma. His efforts include translational research, clinical research, and clinical care. In his laboratory, Dr. Fonseca has led his team of researchers in focusing on the genetic nature of clonal cells in plasma cell disorders, myeloma bone disease, and the development of prognostic markers and new therapies for the disease. Dr. Fonseca has received numerous awards and honors, including the Damon Runyon-Walter Winchell Clinical Investigator Award and the International Waldenström Macroglobulinemia Research Award. He is also a Mayo Clinic Distinguished Investigator, the highest academic distinction given to investigators at his institution.